Data supplements
Supplemental Data
Files in this Data Supplement:
Jump to section
Related Articles
Cited By...
- Approaches to Imaging Immune Activation Using PET
- Exploiting macropinocytosis for therapeutic intervention in RAS mutant Multiple Myeloma
- Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy
- Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer
- Use of Phage Display and Other Molecular Display Methods for the Development of Monobodies
- Imaging cellular immunotherapies and immune cell biomarkers: from preclinical studies to patients
- Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of 89Zr-Labeled Anti-PD-L1 Antibody Formats
- Imaging PD-L1 Expression in Melanoma Brain Metastases
- 18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
- First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients
- Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics
- Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
- Molecular Imaging of PD-L1 Expression and Dynamics with the Adnectin-Based PET Tracer 18F-BMS-986192
- 89Zr-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs
- Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
- Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
- The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody Treatment
- JHU-2545 Selectively Shields Salivary Glands and Kidneys during PSMA-Targeted Radiotherapy
- PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody
- Toward Independent Nuclear Medicine, Molecular Imaging, and Theranostic Programs
- A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues
- The Immunoimaging Toolbox
- Same-Day Imaging Using Small Proteins: Clinical Experience and Translational Prospects in Oncology